PUBLIC CONTRACT · 2022
BEAD20220381 - Glaxosmithkline-prod farmaceuticos,LDA
- Contract value
- €7,018.20
- Signed on
- 6 September 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9457269PUBLISHED SUBJECT
BEAD20220381 - VACINA VIVA CONTRA O ROTAVÍRUS - QUANTIDADES ADICIONAIS
Parties involved
- Place of performance
- Portugal, Região Autónoma da Madeira, Funchal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GLAXOSMITHKLINE-PROD FARMACEUTICOS,LDA · Tax ID 500139962
- Bidder
- MERCK SHARP DOHME · Tax ID 500191360
Values and timeline
- Contract price
- €7,018.20
- Procedure base price
- €80,574.48
- Total effective price
- €7,018.20
- Publication date
- 19 September 2022
- Award date
- 6 September 2022
- Signing date
- 6 September 2022
- Performance period
- 116 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2022/13 - Vacinas e tuberculinas
- Centralised procedure
- Yes
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6042413
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.